Cargando…
人源化CD19 CAR-T细胞治疗儿童及青少年复发难治急性淋巴细胞白血病患者的疗效及安全性
OBJECTIVE: To investigate the efficacy and safety of humanized CD19-specific chimeric antigen receptor T cells（hCART19s）in treating children and young adults with relapsed/refractory acute lymphoblastic leukemia（R/R ALL）and to analyze relevant factors affecting its curative effect and prognosis. MET...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395560/ https://www.ncbi.nlm.nih.gov/pubmed/36709132 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.07.005 |